CTIS.eu › Cities › France › Pierre Benite
Pierre Benite
France
404 total trials
186 recruiting
2024-514471-18-00
5
2020-05-13
Invasive Fungal Diseases in Adults undergoing Allogeneic Blood and Mar
2023-504036-17-00
5
2020-05-07
Chronic Lymphocytic Leukemia (CLL)
2024-512734-15-00
1
2019-10-23
Non-Hodgkin lymphoma and chronic lymphocytic leukemia
2024-515308-38-00
5
2019-09-21
Adults patients with isolated acute urticaria presenting to the emerge
2024-516201-23-00
4
2019-08-26
Lung Cancer, NSCLC
2024-513374-22-00
5
2019-04-30
Short Bowel Syndrome
2023-508343-48-00
5
2019-01-25
Adult patients with relapsed or refractory aggressive B-cell non-Hodgk
2024-516416-22-00
10
2019-01-17
malignancy of thyroid nodules
2024-512158-12-00
5
2018-12-14
Bladder Cancer
Muscle-Invasive Bladder Cancer
2022-502938-30-00
5
2018-12-10
Moderate and Severe Atopic Dermatitis
2024-519336-16-00
10
2018-10-31
Relapsed or Refractory Angioimmunoblastic T cell Lymphoma
2024-515051-38-00
5
2018-07-20
Non-small Cell Lung Cancer
2024-515356-21-00
5
2018-04-17
Adult subject (18 years of age older) with low or intermediate-1 IPSS
2024-516904-40-00
5
2018-03-27
Previously Untreated Diffuse large B-cell lymphoma (DLBCL)
2023-508757-75-00
5
2017-09-18
Stage IV Non-Small Cell Lung Cancer (NSCLC)
2022-501360-18-00
5
2017-03-15
Early Stage Non-Small Cell Lung Cancer (NSCLC)
2024-511967-26-00
5
2016-11-21
AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis)
2024-517856-36-00
5
2015-03-09
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce
2024-514855-13-00
4
DNA repair-deficient or platinum-sensitive solid tumors
2025-520468-16-00
4
Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable
Showing 385–404 of 404 trials